I Slaninová Selected Research

Doxorubicin (Adriamycin)

9/2009

Dibenzocyclooctadiene lignans overcome drug resistance in lung cancer cells--study of structure-activity relationship.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

I Slaninová Research Topics

Disease

2	Carcinoma (Carcinomatosis) 09/2009 - 01/2001
1	Neoplasms (Cancer) 04/2010
1	Lung Neoplasms (Lung Cancer) 09/2009

Drug/Important Bio-Agent (IBA)

2	benzo(c)phenanthridineIBA 04/2010 - 01/2001
2	sanguilutineIBA 04/2010 - 01/2001
2	chelilutineIBA 04/2010 - 01/2001
2	AlkaloidsIBA 04/2010 - 01/2001
1	multidrug resistance-associated protein 1IBA 09/2009
1	dibenzocyclooctadieneIBA 09/2009
1	LignansIBA 09/2009
1	Multidrug Resistance-Associated ProteinsIBA 09/2009
1	schizandrin BIBA 09/2009
1	schizandrin AIBA 09/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2009
1	protoberberineIBA 01/2001
1	chelerythrineIBA 01/2001
1	sanguinarineIBA 01/2001
1	Berberine AlkaloidsIBA 01/2001
1	coptisineIBA 01/2001